Aurinia Pharmaceuticals Inc AUPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:09 PM EDT
5.30quote price arrow up+0.21 (+4.22%)
Volume
1,084,587
52 week range
4.71 - 12.43
Loading...
  • Open5.08
  • Day High5.31
  • Day Low5.07
  • Prev Close5.09
  • 52 Week High12.43
  • 52 Week High Date07/28/23
  • 52 Week Low4.71
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap758.718M
  • Shares Out143.02M
  • 10 Day Average Volume1.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change-41.94

KEY STATS

  • Open5.08
  • Day High5.31
  • Day Low5.07
  • Prev Close5.09
  • 52 Week High12.43
  • 52 Week High Date07/28/23
  • 52 Week Low4.71
  • 52 Week Low Date04/18/24
  • Market Cap758.718M
  • Shares Out143.02M
  • 10 Day Average Volume1.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change-41.94

RATIOS/PROFITABILITY

  • EPS (TTM)-0.55
  • P/E (TTM)-9.73
  • Fwd P/E (NTM)-93.07
  • EBITDA (TTM)-80.044M
  • ROE (TTM)-19.92%
  • Revenue (TTM)175.513M
  • Gross Margin (TTM)91.94%
  • Net Margin (TTM)-44.45%
  • Debt To Equity (MRQ)23.84%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aurinia Pharmaceuticals Inc

 

Profile

MORE
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct pre-clinical, clinical, and regulatory activities to...
Daniel Billen Ph.D.
Chairman of the Board
Peter Greenleaf
President, Chief Executive Officer, Director
Joe Miller
Chief Financial Officer
Matthew Donley
Executive Vice President, Operations and Strategy
Stephen Robertson
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Address
#140, 14315 - 118 AVENUE
Victoria, BC
T5L 4S6
Canada

Top Peers

SYMBOLLASTCHG%CHG
ABUS
Arbutus Biopharma Corp
2.74+0.01+0.37%
CYBN
Cybin Inc
0.3439-0.0061-1.7429%
ZOM
Zomedica Corp
0.142-0.0001-0.0704%
MDNA
Medicenna Therapeutics Corp
2.38+0.06+2.59%
CRDL
Cardiol Therapeutics Inc
2.06+0.05+2.49%